If there are some diagnostic doubts (especially in CD117 immuno-negative suspected GIST), immuno-hystological diagnosis requires CD117 immunopositivity or molecular analysis for activating mutations in KIT or PDGFRA. This evidence concerns the gene KIT and gastrointestinal stromal tumor.